dc.contributor.author | Lindkær-Jensen, Steen | |
dc.contributor.author | Larsen, Stig | |
dc.contributor.author | Lindkær-Jensen, Nina Habib | |
dc.contributor.author | Fagertun, Hans E. | |
dc.date.accessioned | 2015-08-10T12:34:09Z | |
dc.date.accessioned | 2015-08-21T11:41:44Z | |
dc.date.available | 2015-08-10T12:34:09Z | |
dc.date.available | 2015-08-21T11:41:44Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Drug Design, Development and Therapy 2015, 2015(9):1481-1490 | nb_NO |
dc.identifier.issn | 1177-8881 | |
dc.identifier.uri | http://hdl.handle.net/11250/297783 | |
dc.description | - | nb_NO |
dc.language.iso | eng | nb_NO |
dc.rights | Navngivelse 3.0 Norge | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/no/ | * |
dc.title | Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance | nb_NO |
dc.type | Journal article | nb_NO |
dc.type | Peer reviewed | nb_NO |
dc.date.updated | 2015-08-10T12:34:09Z | |
dc.identifier.doi | 10.2147/DDDT.S80451 | |
dc.identifier.cristin | 1253339 | |